Fig. 1.
Fig. 1. The initial and final serum ferritin concentrations in 26 patients who continue deferiprone therapy for a mean of 39.4 (range, 12 to 49) months. (○), Chronic liver disease caused by hepatitis C; threshold of effective treatment: (▧), USA; (▨), WHO.

The initial and final serum ferritin concentrations in 26 patients who continue deferiprone therapy for a mean of 39.4 (range, 12 to 49) months. (○), Chronic liver disease caused by hepatitis C; threshold of effective treatment: (▧), USA; (▨), WHO.

Close Modal

or Create an Account

Close Modal
Close Modal